Neuroproteomics

The Neuroproteomics Special Issue overviews the unique challenges that must be addressed to carry out meaningful MS/proteomics analyses on neural tissues and the technologies that are available to meet these challenges. The articles on Alzheimer’s disease, addiction, and schizophrenia illustrate how...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Williams, Kenneth R., Nairn, Angus C.
Format: Online
Język:angielski
Wydane: MDPI - Multidisciplinary Digital Publishing Institute 2021
Hasła przedmiotowe:
n/a
DIA
PRM
PSD
PKA
Dostęp online:44747
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
_version_ 1869516563579666432
author Williams, Kenneth R.
Nairn, Angus C.
author_browse Nairn, Angus C.
Williams, Kenneth R.
author_facet Williams, Kenneth R.
Nairn, Angus C.
author_sort Williams, Kenneth R.
collection Directory of Open Access Books
description The Neuroproteomics Special Issue overviews the unique challenges that must be addressed to carry out meaningful MS/proteomics analyses on neural tissues and the technologies that are available to meet these challenges. The articles on Alzheimer’s disease, addiction, and schizophrenia illustrate how MS/proteomics technologies can be used to improve our ability to diagnose and understand the molecular basis for neurological diseases. Several articles will be of interest to investigators beyond the field of neurological disorders. The review on the discovery of biofluid biomarkers of neurodegenerative dementias will be of interest to investigators searching for other disease biomarkers. Similarly, the review on the role of neuroproteomics in elucidating mechanisms of drug addiction provides an overview of the utility of MS/proteomics approaches for addressing critical questions in addiction neuroscience that should be applicable to investigators involved in virtually any area of biomedical research. Likewise, the article on developing targeted MS approaches for quantifying postsynaptic density proteins will be useful for any investigator who wishes to design targeted assays for virtually any protein. Finally, the peroxidase-mediated proximity labeling technology, described in the article on mapping the proteome of the synaptic cleft, will be of interest to investigators interested in mapping other spatially restricted proteomes.
format Online
id doab-20.500.12854ir-54529
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-545292024-03-30T23:21:55Z Neuroproteomics Williams, Kenneth R. Nairn, Angus C. R5-920 RC346-429 n/a analgesia quantitative phosphoproteomics neurodegeneration neuron neuronal circuits mating sex-specific differences AMPA receptor complex parallel reaction monitoring splicing phosphorylation peptidylglycine ?-amidating monooxygenase pherophorin Alzheimer’s disease neuroscience yohimbine synapses adolescence conformational antibody opioid receptors protein interaction networks Alzheimer’s Disease transmembrane AMPA receptor regulatory protein neuroproteome ethanol U1 snRNP mass spectroscopy morphine protein phosphatase-1 neuroproteomics axons reinstatement DIA voltage gated channels prohormone convertase postsynaptic density neuroimmune dendrites carboxypeptidase GPCR signaling CaMKII FGF14 SynCAM nicotinic receptor synaptic plasticity plasma serum corticosterone dopamine Receptor-type tyrosine-protein phosphatase zeta Ptprz1 PRM cell type schizophrenia laser capture microdissection synapse specificity LC-MS/MS mouse drug abuse synaptic cleft striatum Cadm cytokine spinophilin PSD trans-synaptic adhesion nicotine proximity labeling biomarkers addiction PKA synapse proteome signal peptide ventral tegmental area protein aggregation cerebrospinal fluid bioinformatics progressive ratio interactome subtilisin affinity chromatography basal ganglia cocaine targeted proteomics postsynaptic mass spectrometry connectome quantitative mass spectrometry biotinylation proteomics amphetamine autism data-independent acquisition excitatory/inhibitory tone neuropeptidomics matrix metalloproteinase cilia R-PTP-zeta cognitive impairment thema EDItEUR::M Medicine and Nursing The Neuroproteomics Special Issue overviews the unique challenges that must be addressed to carry out meaningful MS/proteomics analyses on neural tissues and the technologies that are available to meet these challenges. The articles on Alzheimer’s disease, addiction, and schizophrenia illustrate how MS/proteomics technologies can be used to improve our ability to diagnose and understand the molecular basis for neurological diseases. Several articles will be of interest to investigators beyond the field of neurological disorders. The review on the discovery of biofluid biomarkers of neurodegenerative dementias will be of interest to investigators searching for other disease biomarkers. Similarly, the review on the role of neuroproteomics in elucidating mechanisms of drug addiction provides an overview of the utility of MS/proteomics approaches for addressing critical questions in addiction neuroscience that should be applicable to investigators involved in virtually any area of biomedical research. Likewise, the article on developing targeted MS approaches for quantifying postsynaptic density proteins will be useful for any investigator who wishes to design targeted assays for virtually any protein. Finally, the peroxidase-mediated proximity labeling technology, described in the article on mapping the proteome of the synaptic cleft, will be of interest to investigators interested in mapping other spatially restricted proteomes. 2021-02-11T20:51:18Z 2021-02-11T20:51:18Z 2020-04-07 23:07:08 2020 book 44747 9783039281077 9783039281060 https://directory.doabooks.org/handle/20.500.12854/54529 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/2022 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-03928-107-7 10.3390/books978-3-03928-107-7 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783039281077 9783039281060 318 open access
spellingShingle R5-920
RC346-429
n/a
analgesia
quantitative phosphoproteomics
neurodegeneration
neuron
neuronal circuits
mating
sex-specific differences
AMPA receptor complex
parallel reaction monitoring
splicing
phosphorylation
peptidylglycine ?-amidating monooxygenase
pherophorin
Alzheimer’s disease
neuroscience
yohimbine
synapses
adolescence
conformational antibody
opioid receptors
protein interaction networks
Alzheimer’s Disease
transmembrane AMPA receptor regulatory protein
neuroproteome
ethanol
U1 snRNP
mass spectroscopy
morphine
protein phosphatase-1
neuroproteomics
axons
reinstatement
DIA
voltage gated channels
prohormone convertase
postsynaptic density
neuroimmune
dendrites
carboxypeptidase
GPCR signaling
CaMKII
FGF14
SynCAM
nicotinic receptor
synaptic plasticity
plasma
serum
corticosterone
dopamine
Receptor-type tyrosine-protein phosphatase zeta
Ptprz1
PRM
cell type
schizophrenia
laser capture microdissection
synapse specificity
LC-MS/MS
mouse
drug abuse
synaptic cleft
striatum
Cadm
cytokine
spinophilin
PSD
trans-synaptic adhesion
nicotine
proximity labeling
biomarkers
addiction
PKA
synapse
proteome
signal peptide
ventral tegmental area
protein aggregation
cerebrospinal fluid
bioinformatics
progressive ratio
interactome
subtilisin
affinity chromatography
basal ganglia
cocaine
targeted proteomics
postsynaptic
mass spectrometry
connectome
quantitative mass spectrometry
biotinylation
proteomics
amphetamine
autism
data-independent acquisition
excitatory/inhibitory tone
neuropeptidomics
matrix metalloproteinase
cilia
R-PTP-zeta
cognitive impairment
thema EDItEUR::M Medicine and Nursing
Williams, Kenneth R.
Nairn, Angus C.
Neuroproteomics
title Neuroproteomics
title_full Neuroproteomics
title_fullStr Neuroproteomics
title_full_unstemmed Neuroproteomics
title_short Neuroproteomics
title_sort neuroproteomics
topic R5-920
RC346-429
n/a
analgesia
quantitative phosphoproteomics
neurodegeneration
neuron
neuronal circuits
mating
sex-specific differences
AMPA receptor complex
parallel reaction monitoring
splicing
phosphorylation
peptidylglycine ?-amidating monooxygenase
pherophorin
Alzheimer’s disease
neuroscience
yohimbine
synapses
adolescence
conformational antibody
opioid receptors
protein interaction networks
Alzheimer’s Disease
transmembrane AMPA receptor regulatory protein
neuroproteome
ethanol
U1 snRNP
mass spectroscopy
morphine
protein phosphatase-1
neuroproteomics
axons
reinstatement
DIA
voltage gated channels
prohormone convertase
postsynaptic density
neuroimmune
dendrites
carboxypeptidase
GPCR signaling
CaMKII
FGF14
SynCAM
nicotinic receptor
synaptic plasticity
plasma
serum
corticosterone
dopamine
Receptor-type tyrosine-protein phosphatase zeta
Ptprz1
PRM
cell type
schizophrenia
laser capture microdissection
synapse specificity
LC-MS/MS
mouse
drug abuse
synaptic cleft
striatum
Cadm
cytokine
spinophilin
PSD
trans-synaptic adhesion
nicotine
proximity labeling
biomarkers
addiction
PKA
synapse
proteome
signal peptide
ventral tegmental area
protein aggregation
cerebrospinal fluid
bioinformatics
progressive ratio
interactome
subtilisin
affinity chromatography
basal ganglia
cocaine
targeted proteomics
postsynaptic
mass spectrometry
connectome
quantitative mass spectrometry
biotinylation
proteomics
amphetamine
autism
data-independent acquisition
excitatory/inhibitory tone
neuropeptidomics
matrix metalloproteinase
cilia
R-PTP-zeta
cognitive impairment
thema EDItEUR::M Medicine and Nursing
topic_facet R5-920
RC346-429
n/a
analgesia
quantitative phosphoproteomics
neurodegeneration
neuron
neuronal circuits
mating
sex-specific differences
AMPA receptor complex
parallel reaction monitoring
splicing
phosphorylation
peptidylglycine ?-amidating monooxygenase
pherophorin
Alzheimer’s disease
neuroscience
yohimbine
synapses
adolescence
conformational antibody
opioid receptors
protein interaction networks
Alzheimer’s Disease
transmembrane AMPA receptor regulatory protein
neuroproteome
ethanol
U1 snRNP
mass spectroscopy
morphine
protein phosphatase-1
neuroproteomics
axons
reinstatement
DIA
voltage gated channels
prohormone convertase
postsynaptic density
neuroimmune
dendrites
carboxypeptidase
GPCR signaling
CaMKII
FGF14
SynCAM
nicotinic receptor
synaptic plasticity
plasma
serum
corticosterone
dopamine
Receptor-type tyrosine-protein phosphatase zeta
Ptprz1
PRM
cell type
schizophrenia
laser capture microdissection
synapse specificity
LC-MS/MS
mouse
drug abuse
synaptic cleft
striatum
Cadm
cytokine
spinophilin
PSD
trans-synaptic adhesion
nicotine
proximity labeling
biomarkers
addiction
PKA
synapse
proteome
signal peptide
ventral tegmental area
protein aggregation
cerebrospinal fluid
bioinformatics
progressive ratio
interactome
subtilisin
affinity chromatography
basal ganglia
cocaine
targeted proteomics
postsynaptic
mass spectrometry
connectome
quantitative mass spectrometry
biotinylation
proteomics
amphetamine
autism
data-independent acquisition
excitatory/inhibitory tone
neuropeptidomics
matrix metalloproteinase
cilia
R-PTP-zeta
cognitive impairment
thema EDItEUR::M Medicine and Nursing
url 44747
work_keys_str_mv AT williamskennethr neuroproteomics
AT nairnangusc neuroproteomics